Published in Medical Letter on the CDC and FDA, January 22nd, 2006
Eisai Medical Research Inc. submitted the revised application in December 2005. The sNDA was originally submitted on August 31, 2005, but the FDA did not accept the application for filing due to deficiencies in its format.
An acceptance decision regarding the sNDA resubmission will be made by FDA within 60 days after receipt and review of its contents, according to FDA's usual...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.